Top section
Top section
Follow-on market drives Greece’s strongest year of equity issuance since 2014, but IPO activity still limited
Company will use the proceeds to part-fund its £218m acquisition of 50% stake in Manchester Arndale shopping centre
UK follow-ons bring a secondary employee selldown and an increased primary capital raise
More articles
More articles
More articles
-
Huge demand for exposure to biotech companies among US equity investors is continuing to drive UK firms to list on the other side of the Atlantic through an IPO on the Nasdaq. On Thursday, Immunocore, a late-stage biotech firm focused on T-cell technology, priced an enlarged offering on the exchange and, on Friday, UK healthcare investor Syncona announced it was exploring a US IPO for one of its portfolio companies. -
Hipgnosis Songs Fund, a London-listed investment trust focused on music royalties, has closed its latest share sale, raising £75m.
-
Medical device manufacturer New Horizon Health has pulled in early demand to cover its Hong Kong IPO multiple times over, according to a source familiar with the matter.
-
Thai Beverage is preparing to spin off and list its brewery business, BeerCo, on the Singapore Exchange in a deal expected to raise as much as $2bn.
-
Under its new "Strategy 2024" plan, Commerzbank is considering outsourcing equities services to a partner as several rivals have done. It also wants to focus its equity capital markets and M&A franchises more squarely on existing clients.
-
HSBC's Henry to retire — European Commission borrows IR and funding officials from EIB — Paterson joins CQS
Sub-sections
shared comment list
